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Epidermal growth factor (EGF), 12-0-tetradecanoylphorbol 13-acetate (TPA) and calcium ionophore 
A23187 increase cytoplasmic free calcium ([Ca’+]i) and stimulate arachidonic acid release and production 
of PGE? and 6-keto PGF,,, an end metabolite of PG12, in cultured porcine thyroid cells. Addition of EGF, 
TPA or A23 187 to the cells loaded with fura-2, a fluorescent Ca *+ indicator, causes an immediate increase 
in [Ca*+]i, which is the earliest event after mitogen stimulation. This [Ca*+], response occurs immediately, 
reaching a maximum within several seconds. EGF, TPA and A23 187 stimulate arachidonic acid release and 
PGEz and 6-keto PGF,, production; the maximum effects are obtained after 24 h incubation. EGF, TPA 
and A23 187 increase [Ca*+], and then stimulate arachidonic acid release and PG production. 
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1. INTRODUCTION 
Epidermal growth factor (EGF) and 12-0- 
tetradecanoylphorbol 13-acetate (TPA) are potent 
mitogens for thyroid cells [ 11. In the search for 
putative intracellular mitogenic signals, attention 
has been focused on the earliest detectable events 
following the stimulation by growth factors. The 
initial consequences of growth factor stimulation 
include an increase in [Ca’+]i [2,3] and prostaglan- 
din (PG) production [4]. It is of interest to deter- 
mine whether EGF and TPA increase [Ca*+]i in the 
thyroid gland. We therefore studied the effects of 
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EGF and TPA on [Ca*+]i and report that EGF and 
TPA do in fact increase [Ca*+]i. EGF and TPA 
stimulate the production of PGE2 and 6-keto 
PGFi,, an end metabolite of PGI2, in the thyroid 
gland [4]. This PG production occurs immediately 
after stimulation. A further question concerns 
which event is the earlier, i.e. an increase in [Ca*+]i 
or PG production after mitogen stimulation. This 
report shows that an increase in [Ca*+]i is the 
earliest event after mitogen stimulation in the 
thyroid gland. 
EGF and TPA stimulate PG production [4]. 
However, the mechanism of this process is not 
known. After our initial report [4], we subsequent- 
ly found that the Ca*+ ionophore A23187 also 
stimulates PG production. This raised the 
possibility that EGF- and TPA-stimulated PG pro- 
duction is mediated by an increase in [Ca*+]i. 
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Thus, we studied the effects of EGF, TPA and 
A23187 on [Ca2+]i, arachidonic acid release and 
PG production. This is the first report to show that 
EGF, TPA and A23187 increase [Ca2+]i and 
stimulate arachidonic acid release and PG produc- 
tion. The results indicate that EGF, TPA and 
A23187 stimulate PG production through an in- 
crease in [Ca2+]i. An increase in [Ca2’]i is the 
earliest event after mitogen stimulation and occurs 
immediately after stimulation. 
2. MATERIALS AND METHODS 
2.1. Thyroid cell culture 
Thyroid cells were obtained from porcine 
thyroid glands as described [5]. Freshly isolated 
cells were suspended (3 x lo6 cells/ml) in Eagle’s 
minimum essential medium (EMEM) sup- 
plemented with 1% fetal calf serum and antibiotics 
(penicillin, 200 U/ml; streptomycin, 50 pg/ml). 
Cells were cultured as a suspension at 37°C in a 
95% air:5% < 201 ! water-saturated atmosphere. 
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Isolated thyroid cells were cultured for 16 h and 
the cells then loaded with fura-2, as in [6]. Fura- 
AM (1 PM final concentration) was added to the 
EMEM buffered with 10 mM Hepes (pH 7.4). The 
cells were incubated for 45 min under the culture 
conditions. Under these conditions, fura- AM 
permeates the cells, is hydrolyzed to fura-2, and 
binds cytoplasmic free calcium. To remove the 
unincorporated probe, cells were centrifuged for 
3 min at 500 x g, and washed in PBSG-Hepes solu- 
tion, consisting of 137 mM NaCl, 2.7 mM KCl, 
8.1 mM Na2HP04, 1.5 mM KH2P04, 0.45 mM 
CaC12, 0.49 mM MgC12, 5.6 mM glucose and 
10 mM Hepes [12]. The cells were washed twice 
and resuspended in the same buffer ( lo6 cells/ml). 
The cell suspension was transferred to a ther- 
mostatted quartz cuvette (37”C), for measurement 
of calcium concentrations ([Ca”]i) in a Hitachi 
F-3000 fluorimeter (Hitachi, Tokyo). After 
reaching a steady state, EGF, TPA or A23187 was 
added to the cuvette using a syringe. Fluorescence 
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2.2. [(ca”]i measurement by fura- 
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Fig.1. EGF (A), TPA (B) and Ca *+ ionophore A23187 (C) induced rise in [Ca*+]i. The fura-2-loaded cells were 
stimulated by lo-” M EGF (A), lo-” M TPA (B) or lo-’ M A23187 (C) as indicated by an arrow. Horizontal bar 
(1 m) = 1 min. 
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was recorded with excitation and emission 
wavelengths of 340 and 505 nm, respectively. 
[Ca’+]i was determined as described by Gryn- 
ciewicz et al. [6]. 
figures. Student’s t-test was used for statistical 
evaluations. 
3. RESULTS 
2.3. A rachidonic acid release 3.1. EGF-, TPA- and A23187-induced increases in 
Isolated thyroid cells were cultured for 16 h and 
then cells incubated with [l-14C]arachidonic acid 
(4 &i/ml) (70.2 Ci/mmol, New England Nuclear, 
Boston, MA). After 16 h, i.e. in the plateau phase 
of the labeling kinetics, the cells were washed twice 
with the medium and then suspended in EMEM 
supplemented with 0.5% fetal calf serum. To 
measure arachidonic acid release, 3 ml of the cell 
suspension (3 x 106/ml) were incubated with EGF, 
TPA or A23187 under the culture conditions. 
After appropriate time intervals, 1 ml medium was 
removed, acidified to pH 4 with 0.1 N HCl and ex- 
tracted twice with 4 and 2 ml ethyl acetate, respec- 
tively. After vacuum evaporation of the solvent the 
residue was chromatographed on silica gel plate 
60 F (Merck, Darmstadt). The upper phase 
of isooctane/water/ethyl acetate/acetic acid 
(50: 100: 110: 20) was used as a solvent and the 
plate was developed. Reference spots were visual- 
ized with iodide vapor. Arachidonic acid spots 
were scraped and the radioactivities were deter- 
mined using a liquid scintillation counter. 
The cells were loaded with fura-2. The basal 
[Ca*+]i was estimated as 106 f 10 nM (mean f SE, 
n = 20). Addition of 10-i’ M EGF, lo-” M TPA 
or lo-’ M A23 187 resulted in a prompt increase in 
[Ca*+]i (fig. 1). The increase was immediate with no 
detectable lag period. A peak in [Ca*+]i was 
observed within several seconds after addition of 
EGF, TPA or A23187, followed by a gradual 
decrease. Graded doses of EGF, TPA or A23187 
increased [Ca*+]i and the peak [Ca*‘]i concentra- 
tions after stimulation are shown (fig.2). The ef- 
fect of EGF or TPA on [Ca*+]i was observed at 
10-r’ M (P < 0.05) and was maximal at lo-’ M. 
2.4. Prostaglandin production 
Isolated thyroid cells were cultured for 16 h and 
then washed. After washing, cells were incubated 
in the absence or presence of EGF, TPA or A23 187 
under the culture conditions. After several hours 
of incubation, cells and medium were collected and 
the concentrations of PGEz and 6-keto PGFi,, an 
end metabolite of PGI2, were measured, as 
reported in [8]. 
2.5. Materials etc. 
Murine EGF was obtained from Collaborative 
Research (Waltman, MA), TPA and A23 187 from 
Sigma (St. Louis, MO), TSH from Armour Phar- 
maceutical (Phoenix, AZ), and fetal calf serum 
and Eagle’s MEM (EMEM) from Flow 
Laboratories (Irvine, Scotland). All other 
chemicals were of the highest purity available com- 
mercially. Experiments were conducted at least 4 
times. Typical data and the final concentrations of 
EGF, TPA and A23187 are shown in the text and 
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Fig.2. Effects of graded doses of EGF (o), TPA (0) 
and A23187 (0) on [Ca’+]i. Fura-2-loaded cells were 
stimulated with graded doses of EGF (o), TPA ( q ) and 
A23187 (0) and the peak [Ca’+]i values are shown. 
Results shown are the mean of four sets of experiments 
using different cell preparations. 
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TIME hours) 
Fig.3. Effects of EGF (o), TPA (0) and A23187 (0) on 
arachidonic acid release (A), and PGE2 (B) and 6-keto 
PGFi, (C) production. Isolated thyroid cells were 
cultured for 16 h and then washed. After washing, cells 
were incubated in the absence (w) or presence of 10-s M 
EGF (o), lOmE M TPA (0) or 10m6 M A23187 (0). 
After O-5 h incubation, arachidonic acid release (A), 
and PGEz (B) and 6-keto PGFi, (C) production were 
measured. Each point is the mean * SE of 3-5 
determinations. 
0 
(0) 12 10 8 6 
EGF(a), TPAU), A 23187(o), -‘w10 M 
Fig.4. Effects of graded doses EGF (o), TPA (0) and 
A23 187 (0) on arachidonic acid release (A), and PGE2 
(B) and 6-keto PGFr, (C) production. Isolated thyroid 
cells were cultured for 16 h and then washed. After 
washing, cells were incubated in the presence of graded 
doses of EGF (o), TPA (0) or A23187 (0) for 2 (A) or 
4 h (B,C). Then arachidonic acid release (A), and PGE2 
(B) and 6-keto PGFr, (C) production were measured. 
Each point is the mean + SE of 3-5 determinations. 
The effect of A23187 on [Ca2+]i was evident at 5 
x 10m9 M (P < 0.05) and was maximal at 10e6 M. 
The A23 187~stimulated maximal increase in 
[Ca’+]i was higher than that of EGF or TPA. 
3.2. EGF-, TPA- and A23187-stimulated increases 
in arachidonic acid release and PG 
production 
Addition of 10m8 M EGF, 10e8 M TPA and 
10e6 M A23 187 stimulated arachidonic acid release 
and PGE2 and 6-keto PGFi, production (fig.3); 
maximum arachidonic acid release and PG pro- 
duction were obtained after 2 and 3-4 h incuba- 
tion, respectively. Graded doses of EGF, TPA or 
A23 187 stimulated arachidonic acid release and 
PG production (fig.4); 10-i’ M EGF, lo-” M 
TPA and 5 x 10e9 M A23187 stimulated 
arachidonic acid release and PG production 
significantly (P < 0.05), with maxima being ob- 
tained with 10e8 M EGF, lo-’ M TPA and 
1O-6 M A23187. The magnitude of increases in 
arachidonic acid release and PG production was 
the greatest with TPA and the least with A23187. 
4. DISCUSSION 
EGF, TPA and A23187 increase [Ca2+]; and 
stimulate arachidonic acid release and PGE2 and 
6-keto PGFi, production in cultured porcine 
thyroid cells. An increase in [Ca’+]i is the earliest 
event after EGF, TPA or A23187 stimulation. 
EGF, TPA and A23 187 stimulate arachidonic acid 
release and PGE2 and 6-keto PGFr, production 
through an increase in [Ca’+]i. 
EGF and TPA are potent mitogens for thyroid 
cells [l]. EGF and TPA stimulate PG production, 
which was thought to be one of the early processes 
of thyroid cell proliferation [4]. However, we 
found that the earliest event to occur in response to 
EGF or TPA is an increase in [Ca’+]i, which 
stimulates arachidonic acid release and PG pro- 
duction. 
EGF and TPA stimulate PG production in the 
thyroid gland [4]. However, the underlying 
mechanism remains unknown. In the thyroid gland 
A23187 has been believed to increase [Ca2+]i and 
actually does so. A23 187 also stimulates 
arachidonic acid release and PG production. EGF 
and TPA increase [Ca2+]i and subsequently 
stimulate arachidonic acid release and PG produc- 
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tion. These results support the concept that the 
EGF-, TPA- or A23187-stimulated increase in 
[Ca’+]i induces arachidonic acid release and PG 
production. In the thyroid gland, it was reported 
that stimulation of endogenous phospholipase AZ 
caused the release of arachidonic acid from 
phosphatidylinositol and then increased PG pro- 
duction [9]. Phospholipase AZ seems to be 
stimulated by calcium [lo]. The EGF-, TPA- and 
A23 187-stimulated increases in [Ca2+]i activate 
phospholipase AZ, which stimulates arachidonic 
acid release and PG production. 
EGF and TPA stimulate thyroid cell prolifera- 
tion [ 11. The earliest event to occur in response to 
EGF and TPA thus far reported is an increase in 
[Ca2+]i. However, it is not known how an increase 
in [Ca’+]i stimulates cell proliferation. The 
stimulation of arachidonic acid release and PG 
production by an increase in [Ca2’]i raised the 
possibility that EGF- and TPA-stimulated cell pro- 
liferation is mediated by some PGs. This possibili- 
ty is currently under investigation in our 
laboratory. Stimulation of proliferation by some 
PGs has been reported in other systems [ 111. 
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